LAVAL, Quebec, May 10, 2017 /CNW/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that Joseph C. Papa, chairman and chief executive officer, is scheduled to present at the following health care conferences:
A live webcast and audio archive of the events will be available on Valeant's Investor Relations website and via this URL: http://ir.valeant.com/events-and-presentations
About Valeant
Valeant Pharmaceuticals International, Inc. (NYSE/TSX:VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, gastrointestinal disorders, eye health, neurology and branded generics. More information about Valeant and forward looking statements can be found at www.valeant.com.
Contact Information
Investors:
Elif McDonald
[email protected]
514-856-3855
877-281-6642 (toll free)
Media:
Lainie Keller
[email protected]
908-927-0617
SOURCE Valeant Pharmaceuticals International, Inc.
Share this article